SHARON RAWISZER: Open Payments
NPI 1659156347 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 34 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 8 | $289 |
| Otsuka America Pharmaceutical, Inc. | 7 | $156 |
| Lilly USA, LLC | 6 | $107 |
| Lundbeck LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| TG Therapeutics, Inc. | 1 | $27 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
| UCB, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
Products named: Leqembi, REXULTI, AMYVID, HYQVIA, Symbravo, BRIUMVI, NUPLAZID, Rystiggo.
Industry payments across TN — which companies pay providers there.
